Skip to main content

IFF to Merge with DuPont’s Nutrition & Biosciences Business

Press releases | December 16, 2019

Fried Frank acted as counsel to Evercore Inc. as financial advisor to DuPont in its merger with IFF, in which IFF and Dupont's Nutrition & Biosciences business will merge in a Reverse Morris Trust transaction. The deal has an enterprise value of $26.2 billion. Under the terms of the agreement, DuPont shareholders will own 55.4% of the shares of the combined company and existing IFF shareholders will own 44.6%. Upon completion of the transaction, DuPont will receive a one-time $7.3 billion special cash payment, subject to certain adjustments. The deal is expected to close by early 2021. 

The Fried Frank team was led by partner Philip Richter.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.